The legality and certainty of administrative licensing for drug registration are core symbols of the modernization of the country's drug regulatory system. In the context of multiple links and departments participating in drug registration, it is particularly important to balance the right to statement and defense of drug registration applicants with the maintenance of administrative efficiency. This paper sorted out the dispute resolution mechanisms involved in the current drug registration process, analyzed the ambiguous areas in procedure connection and determination of the effect of conclusions, as well as the challenges they pose to the scientificity and authority of administrative licensing decisions. It also proposed preliminary suggestions to improve China's drug registration dispute resolution mechanism from the legislative, institutional and procedural levels, aiming to provide references for building a drug registration dispute resolution mechanism with clear power and responsibilities, fair procedures, smooth connection and efficient operation.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |